Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic

Yinsu Zhu1, Eun-Ah Park, Whal Lee

  • 1Department of Radiology, Seoul National University Hospital, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-744, Korea.

European Radiology
|January 19, 2015
PubMed

Insights

In hypertrophic cardiomyopathy (HCM), late gadolinium enhancement (LGE) at right ventricular insertion points (RVIP) is linked to higher left ventricular filling pressures. This RVIP-LGE extent independently predicts diastolic dysfunction in HCM patients.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Medical Diagnostics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic heart muscle disease.
  • Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) identifies myocardial scar tissue.
  • Right ventricular insertion points (RVIP) are areas of the myocardium susceptible to LGE in HCM.

Purpose of the Study:

  • To investigate the association between the extent of LGE at RVIP and left ventricular (LV) functional parameters in HCM patients.
  • To determine if RVIP-LGE is an independent predictor of diastolic dysfunction in HCM.

Main Methods:

  • Sixty-one HCM patients underwent echocardiography and CMR.
  • LGE extent was quantified at RVIP (% RVIP-LGE) and non-RVIP locations.
  • LV functional parameters, including E/E' and left atrial volume index (LAVI), were assessed.

Main Results:

  • RVIP-LGE was more frequent in non-apical HCMs and associated with higher E/E' (19.23±8.40 vs. 13.13±5.06) and increased LAVI.
  • RVIP-LGE extent correlated with LV diastolic dysfunction (E/E': r=0.45; LAVI: r=0.53) and lower LVEF (r=-0.42).
  • Non-RVIP-LGE extent showed no correlation with LV diastolic parameters.

Conclusions:

  • The extent of LGE at RVIPs in HCM patients is associated with increased estimated LV filling pressure.
  • RVIP-LGE is an independent predictor of diastolic dysfunction and chronic diastolic burden in HCM.
  • LGE at non-RVIP locations does not correlate with LV diastolic dysfunction in HCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
806
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
1.0K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
513
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
924
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
807